Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241904 · ClinicalTrials.gov registry record · Phase 4
Reducing Total Cardiovascular Risk in an Urban Community
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 525
- Enrollment target
NCT00241904: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT00241904 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 525 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241904, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 525 participants
- Enrollment target
Study Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Primary Outcome
Blood was drawn after a 12 hour fast and low density lipoprotein cholesterol was measured in a standardized lab
Interventions
- DRUG Beta Blocker
- DRUG ACE Inhibitors
- BEHAVIORAL Lifestyle Changes
- DRUG Antiplatelet Agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2006-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
What the finished NCT00241904 record still lists
NCT00241904 is an interventional study that assigns participants to a tested intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 4 interventions - of which Beta Blocker is the first listed.
NCT00241904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00241904 about?
NCT00241904 is a clinical study titled "Reducing Total Cardiovascular Risk in an Urban Community". PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention wit...
What is the current status of trial NCT00241904?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 525 participants. The study started on 2006-05. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00241904?
The interventions under investigation include: Beta Blocker (DRUG), ACE Inhibitors (DRUG), Lifestyle Changes (BEHAVIORAL), Antiplatelet Agents (DRUG).
Who is sponsoring clinical trial NCT00241904?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00241904's enrollment target sits among peer trials
525 157th of 2000 higher than 1,844 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
- NCT06496646 · 525 participants · NA
Antidepressant Adherence for Depressed Adults in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia